Lavie G - Search Results

1

The nitroxide antioxidant tempol is cerebroprotective against focal cerebral ischemia in spontaneously hypertensive rats.

Leker RR, Teichner A, Lavie G, Shohami E, Lamensdorf I, Ovadia H. Leker RR, et al. Among authors: lavie g. Exp Neurol. 2002 Aug;176(2):355-63. doi: 10.1006/exnr.2002.7910. Exp Neurol. 2002. PMID: 12359177

2

Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia.

Lavie G, Teichner A, Shohami E, Ovadia H, Leker RR. Lavie G, et al. Brain Res. 2001 May 18;901(1-2):195-201. doi: 10.1016/s0006-8993(01)02356-3. Brain Res. 2001. PMID: 11368967

3

Combination of dexanabinol and tempol in focal cerebral ischemia: is there a ceiling effect?

Teichner A, Ovadia H, Lavie G, Leker RR. Teichner A, et al. Among authors: lavie g. Exp Neurol. 2003 Aug;182(2):353-60. doi: 10.1016/s0014-4886(03)00083-9. Exp Neurol. 2003. PMID: 12895446

4

Wavelength-dependent properties of photodynamic therapy using hypericin in vitro and in an animal model.

Blank M, Kostenich G, Lavie G, Kimel S, Keisari Y, Orenstein A. Blank M, et al. Among authors: lavie g. Photochem Photobiol. 2002 Sep;76(3):335-40. doi: 10.1562/0031-8655(2002)076<0335:wdpopt>2.0.co;2. Photochem Photobiol. 2002. PMID: 12403456

5

Effects of photodynamic therapy with hypericin in mice bearing highly invasive solid tumors.

Blank M, Lavie G, Mandel M, Keisari Y. Blank M, et al. Among authors: lavie g. Oncol Res. 2000;12(9-10):409-18. doi: 10.3727/096504001108747864. Oncol Res. 2000. PMID: 11697819

6

Enhanced ubiquitinylation of heat shock protein 90 as a potential mechanism for mitotic cell death in cancer cells induced with hypericin.

Blank M, Mandel M, Keisari Y, Meruelo D, Lavie G. Blank M, et al. Among authors: lavie g. Cancer Res. 2003 Dec 1;63(23):8241-7. Cancer Res. 2003. PMID: 14678981

7

Anti-cancer activities of hypericin in the dark.

Blank M, Mandel M, Hazan S, Keisari Y, Lavie G. Blank M, et al. Among authors: lavie g. Photochem Photobiol. 2001 Aug;74(2):120-5. doi: 10.1562/0031-8655(2001)074<0120:acaohi>2.0.co;2. Photochem Photobiol. 2001. PMID: 11547544

8

Antimetastatic activity of the photodynamic agent hypericin in the dark.

Blank M, Lavie G, Mandel M, Hazan S, Orenstein A, Meruelo D, Keisari Y. Blank M, et al. Among authors: lavie g. Int J Cancer. 2004 Sep 10;111(4):596-603. doi: 10.1002/ijc.20285. Int J Cancer. 2004. PMID: 15239139

9

"Competitive quenching": a mechanism by which perihydroxylated perylenequinone photosensitizers can prevent adverse phototoxic damage caused by verteporfin during photodynamic therapy.

Lavie G, Barliya T, Mandel M, Blank M, Ron Y, Orenstein A, Livnat T, Friedman N, Weiner L, Sheves M, Weinberger D. Lavie G, et al. Photochem Photobiol. 2007 Sep-Oct;83(5):1270-7. doi: 10.1111/j.1751-1097.2007.00171.x. Photochem Photobiol. 2007. PMID: 17880523

10

Competitive quenching: a possible novel approach in protecting RPE cells from damage during PDT.

Weinberger D, Ron Y, Lusky M, Gaaton D, Orenstein A, Blank M, Mandel M, Livnat T, Barliya T, Lavie G. Weinberger D, et al. Among authors: lavie g. Curr Eye Res. 2005 Apr;30(4):269-77. doi: 10.1080/02713680590927597. Curr Eye Res. 2005. PMID: 16020257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters